A Clinical Decision Tree to Predict Whether a Bacteremic Patient is Infected with an Extended-Spectrum β-Lactamase-Producing Organism

Clinical Infectious Diseases

Volumn 63, Issue 7, 2016, Pages 896-903

  Goodman, Katherine E ^a   Lessler, Justin ^a   Cosgrove, Sara E ^b   Harris, Anthony D ^c   Lautenbach, Ebbing ^d   Han, Jennifer H ^d   Milstone, Aaron M ^b   Massey, Colin J ^b   Tamma, Pranita D ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bacteremia; carbapenem; ESBL; machine learning; prediction

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; DECISION TREE; DEVICE INFECTION; DRUG EXPOSURE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HOSPITALIZATION; HUMAN; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SPECIES IDENTIFICATION; AGED; ANTIBIOTIC RESISTANCE; CLINICAL DECISION SUPPORT SYSTEM; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; KLEBSIELLA; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DECISION SUPPORT SYSTEMS, CLINICAL; DECISION TREES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS;

EID: 84990909262     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw425     Document Type: Article

References (34)

1. Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:155-64.
2. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.
3. Menashe G, Borer A, Yagupsky P, et al. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Scand J Infect Dis 2001; 33:188-93.
4. Kang CI, Kim SH, Park WB, et al. Bloodstream infections due to extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004; 48:4574-81.
5. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55:943-50.
6. Tamma PD, Han JH, Rock C, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis 2015; 60:1319-25.
7. Armand-Lefevre L, Angebault C, Barbier F, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 2013; 57:1488-95.
8. McLaughlin M, Advincula MR, Malczynski M, et al. Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Chemother 2013; 57:5131-3.
9. Dodemont M, De Mendonca R, Nonhoff S, Roisin S, Denis O. Performance of the Verigene gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol 2014; 52:3085-7.
10. Denis B, Lafaurie M, Donay JL, et al. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis 2015; 39:1-6.
11. Van Aken S, Lund N, Ahl J, Odenholt I, Tham J. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum beta-lactamaseproducing Escherichia coli bacteraemia. Scand J Infect Dis 2014; 46:753-62.
12. Nguyen ML, Toye B, Kanji S, Zvonar R. Risk factors for and outcomes of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species at a Canadian tertiary care hospital. Can J Hosp Pharm 2015; 68:136-43.
13. Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 2009; 14:323-48.
14. Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression trees. Boca Raton, Florida: CRC/Chapman &Hall, 1984.
15. Centers for Disease Control and Prevention. Antimicrobial resistant phenotype definitions. Available at: http://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/ phenotype-definitions.pdf. Accessed 7 April 2016.
16. Ostholm-Balkhed A, Tarnberg M, Nilsson M, Nilsson LE, Hanberger H, Hallgren A. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 2013; 68:2144-53.
17. Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum beta lactamase-producing Enterobacteriaceae. Clin Infect Dis 2015; 60:837-46.
18. Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Series B 1996; 58:267-88.
19. Duda RO, Hart PE, Stork DG. Pattern classification. 2nd ed. Hoboken, NJ: Wiley Interscience, 2001.
20. Chen S, Ishwaran H. Pathway hunting by random survival forests. Bioinformatics 2013; 29:99-105.
21. Boulesteix AL, Janitza S, Hapfelmeier A, Van Steen K, Strobl C. On the term 'interaction' and related phrases in the literature on random forests. Brief Bioinform 2015; 16:338-45.
22. Thaden JT, Fowler VG, Sexton DJ, Anderson DJ. Increasing incidence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States. Infect Control Hosp Epidemiol 2016; 37:49-54.
23. Hilty M, Betsch BY, Sogli-Stuber K, et al. Transmission dynamics of extendedspectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012; 55:967-75.
24. Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 2013; 163:1417-21.
25. Fan NC, Chen HH, Chen CL, et al. Rise of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect 2014; 47:399-405.
26. Megged O. Extended-spectrum beta-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr Nephrol 2014; 29:1583-7.
27. Morgand M, Vimont S, Bleibtreu A, et al. Extended-spectrum beta-lactamaseproducing Escherichia coli infections in children: are community-acquired strains different from nosocomial strains? Int J Med Microbiol 2014; 304:970-6.
28. Madigan T, Johnson JH, Clabots C, et al. Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum beta-lactamase-producing Escherichia coli sequence type 131. Clin Infect Dis 2015; 61:e5-12.
29. Kaarme J, Molin Y, Olsen B, Melhus A, et al. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr 2013; 102:655-60.
30. Lazarus B, Paterson DL, Mollinger JL, Rogers BA. Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review. Clin Infect Dis 2015; 60:439-52.
31. Agerso Y, Jensen JD, Hasman H, Pedersen K. Spread of extended spectrum cephalosporinase-producing Escherichia coli clones and plasmids from parent animals to broilers and to broiler meat in a production without use of cephalosporins. Foodborne Pathog Dis 2014; 11:740-6.
32. Olsen RH, Bisgaard M, Lohren U, Robineau B, Christensen H. Extended-spectrum beta-lactamase-producing Escherichia coli isolated from poultry: a review of current problems, illustrated with some laboratory findings. Avian Pathol 2014; 43:199-208.
33. Voets GM, Fluit AC, Scharringa J, et al. Identical plasmid AmpC beta-lactamase genes and plasmid types in E. coli isolates from patients and poultry meat in the Netherlands. Int J Food Microbiol 2013; 167:359-62.
34. Centers for Disease Control and Prevention. CDC laboratory detection of extendedspectrum β-lactamases (ESBLs). Available at: http://www.cdc.gov/HAI/settings/lab/ lab-esbl.html. Accessed 26 May 2016.